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CASE REPORTAcute generalized exanthematous pustulosis
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Erythematous and edematous eruption, with numerous
pinpoint pustules on the dorsum of the hand.
Abbreviations used:
AGEP: Acute generalized exanthematous
pustulosis
EBV: Epstein-Barr virusA
cute generalized exanthematous pustulosis
(AGEP) is a rare severe cutaneous reaction
characterized by the acute onset of general-
ized nonfollicular sterile pustules arising on an
edematous erythema. The eruption is usually asso-
ciated with fever and neutrophilic leukocytosis.1
Although AGEP is precipitated by drugs in most
cases, there have been isolated reports of AGEP
associated with infections (parvovirus B19, cytomeg-
alovirus, coxsackie B4, Mycoplasma pneumoniae),
mercury exposure, and spider bites.2-5 Herein, we
report the occurrence of AGEP possibly triggered by
an acute primary Epstein-Barr virus (EBV) infection
in a 16-year-old girl.
CASE REPORT
The girl presented to the emergency department
with a 3-day history of a generalized pruritic eruption
of abrupt onset. She complained of fever (39.48C)
and chills in addition to a sore throat and fatigue. She
denied taking any medications before the skin
eruption occurred, and she had no personal or
family history of skin disease. Physical examination
found erythematous and edematous patches, with
numerous nonfollicular pustules on the face, trunk,
and extremities (Fig 1). The patient had minimal
pharyngeal erythema and enlarged cervical lymph
nodes. The remainder of the examination findings
were normal.
Laboratory studies found marked leukocytosis of
19100/L, with neutrophilia (9220/L; normal, 1800-
7500/L), eosinophilia (2670/L; normal,\800/L),
lymphocytosis (5520/L; normal, 1000-4000/L),
monocytosis (1580/L; normal,\1000/L), and an
elevated C-reactive protein level (38.5 mg/L; normal,the Department of Dermatologya, Centre Hospitalier de
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Blood, urine, and pustule cultures for bacteria were
negative. Serologic tests for parvovirus B19,JAAD Case Reports 2015;1:9-11.
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Fig 3. Acute generalized exanthematous pustulosis.
Typical superficial postpustular desquamation after 2
weeks.
Fig 2. Acute generalized exanthematous pustulosis. A
skin biopsy shows a subcorneal pustule filled with
neutrophils. Note the presence of necrotic keratinocytes
in the epidermis. Papillary dermal edema and superficial
mixed infiltrate composed of lymphocytes and neutrophils
can also be seen. (Hematoxylin-eosin stain; original
magnification: 3200.)
Table I. AGEP validation score of the EuroSCAR
study group
Morphology
Pustules
Typical* 12
Compatibley 11
Insufficientz 0
Erythema
Typical 12
Compatible 11
Insufficient 0
Distribution/pattern
Typical 12
Compatible 11
Insufficient 0
Postpustular desquamation
Yes 11
No/insufficient 0
Course
Mucosal involvement
Yes 2
No 0
Acute onset (\10 d)
Yes 0
No 2
Resolution (\15 d)
Yes 0
No 4
Fever ([388C)
Yes 11
No 0
PNN ([7000/L)
Yes 11
No 0
Histology
Other disease 10
Not representative/no histology 0
Exocytosis of PNN 11
Subcorneal and/or intraepidermal non spongi-
form or NOS pustules with papillary edema or
subcorneal and/or intraepidermal spongiform
or NOS pustules without papillary edema
12
Spongiform subcorneal and/or intraepidermal
pustules with papillary edema
13
Interpretation: # 0: no AGEP; 1-4: possible; 5-7: probable; 8-12:
definite.
NOS, not otherwise specified; PNN, polymorphonuclear
neutrophils.
*Typical: typical morphology.
yCompatible: not typical, but not strongly suggestive of other
disease.
zInsufficient: lesions cannot be judged.
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atitis B virus, hepatitis C virus, human immunodefi-
ciency virus, and toxoplasmosis were all negative.
EBV serologic test result was positive for immuno-
globulin M against viral capsid antigen, consistent
with an acute EBV infection. A skin biopsy found
spongiform subcorneal and intraepidermal neutro-
philic pustules along with papillary dermal edema,
superficial lymphocytic infiltrate with neutrophils,
and focal necrosis of keratinocytes (Fig 2). According
to the EuroSCAR study group criteria,1 our patient
had a score of 11, indicating a definite diagnosis of
AGEP. The patient was then treated symptomatically
with topical corticosteroids and emollients, resulting
in rapid resolution of the rash within 2 weeks
followed by a postpustular desquamation (Fig 3).
DISCUSSION
AGEP is a rare acute pustular reaction that is most
often caused by drugs. It is a self-limiting disease,usually arising rapidly, within 48 hours after drug
exposure, and resolving quickly, within 2 weeks
after withdrawal of the causative agent. In typical
cases, the pustules are followed by characteristic
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the EuroSCAR study, antibiotics (such as amino-
penicillins, pristinamycin, and quinolones), terbina-
fine, antimalarials, and calcium channel blockers
(diltiazem) are the most frequently reported triggers
of AGEP.6 The diagnostic criteria include an acute
pustular eruption, fever ([388C), blood neutrophilia
([7000/L), spongiform subcorneal or intraepider-
mal pustules on skin biopsy, and acute evolution and
spontaneous resolution of the pustules in less than
15 days.1 Our patient fulfilled the diagnostic criteria
for AGEP (Table I). AGEP is, however, an uncommon
condition in children, and certain investigators have
suggested that viral infections might be the most
frequent triggers in the pediatric population.7 The
main differential diagnosis of AGEP is generalized
pustular psoriasis. In our patient, the absence of a
personal or family history of psoriasis, the acute
course and rapid resolution of the rash, and the
presence of necrotic keratinocytes on histologic
examination supported a diagnosis of AGEP.
Although the pathogenesis of AGEP is not
well understood, it is postulated to include T
cellemediated neutrophilic inflammation involving
drug-specific CD41 T cells, cytotoxic CD81 T cells,
and inflammatory cytokines and chemokines.8 In
immunocompetent patients, infectious mononucle-
osis represents a benign, self-limiting lymphoproli-
ferative disorder characterized by primary EBV
infection of B lymphocytes and massive proliferation
of highly activated cytotoxic CD81 T cells,
believed to be responsible for the control of viral
replication and the establishment of latency.9 In
our patient, it might be hypothesized that this
vigorous immune response to EBV by cytotoxic
CD81 lymphocytes triggered the appearance of
AGEP. To the best of our knowledge, in addition
to our case, there has been only one otherreported case of AGEP associated with acute
EBV infection.10 However, in that case, AGEP
developed 4 days after starting treatment with
amoxicillin/clavulanic acid, which represents the
most likely inciting agent.
The current case suggests that acute EBV infection
should be considered as an additional trigger of
AGEP, particularly in the pediatric population.
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